4//SEC Filing
Coyne Terrance P. 4
Accession 0001814876-25-000011
CIK 0001802768other
Filed
Dec 16, 7:00 PM ET
Accepted
Dec 17, 5:39 PM ET
Size
10.1 KB
Accession
0001814876-25-000011
Insider Transaction Report
Form 4
Coyne Terrance P.
EVP & CFO
Transactions
- Sale
Class A Ordinary Shares
2025-12-15$38.36/sh−65,832$2,525,322→ 526,660 total(indirect: By LLC) - Sale
Class A Ordinary Shares
2025-12-15$38.36/sh−3,750$143,850→ 43,510 total(indirect: By LLC)
Holdings
- 24,170(indirect: By Spouse)
Class A Ordinary Shares
- 23,270(indirect: By IRA)
Class A Ordinary Shares
- 1,500
Class A Ordinary Shares
- 1,450(indirect: By Spouse)
Class A Ordinary Shares
Footnotes (2)
- [F1]All reported transactions were effected pursuant to a 10b5-1 plan adopted by the Reporting Person on August 8, 2025.
- [F2]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.10 to $38.48 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Documents
Issuer
Royalty Pharma plc
CIK 0001802768
Entity typeother
Related Parties
1- filerCIK 0001814876
Filing Metadata
- Form type
- 4
- Filed
- Dec 16, 7:00 PM ET
- Accepted
- Dec 17, 5:39 PM ET
- Size
- 10.1 KB